Project Grant HT94252310937
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $810,032 to Michigan State University to conduct research on neurobiological mechanisms to alleviate comorbid pain and obesity. The research will take place at Michigan State University's campus in East Lansing, Michigan and is expected to be completed by August 31, 2027. No details were provided on any sub-award recipients or services delivered under the grant.
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This federal Project Grant award of $1,206,372.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Michigan to investigate the role of primary cilia alterations in the pathogenesis and treatment of systemic sclerosis. The 4-year award, running from April 15, 2025 to April 14, 2029, will enable researchers to conduct advanced biomedical research into innovative approaches for diagnosing, preventing, and...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...